Khanna, D, Denton, CP, Jahreis, A, van Laar, JM, Frech, TM, Anderson, ME, Baron, M, Chung, L, Fierlbeck, G, Lakshminarayanan, S et al (show 14 more authors)
(2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
The Lancet, 387 (10038).
2630 - 2640.
This is the latest version of this item.
![]() |
Text
101101617 SSc Ms rev FINAL Tracked.docx - Accepted Version Download (7MB) |
Item Type: | Article |
---|---|
Depositing User: | Symplectic Admin |
Date Deposited: | 25 Jan 2019 11:31 |
Last Modified: | 26 Jan 2021 23:11 |
DOI: | 10.1016/S0140-6736(16)00232-4 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3030738 |
Available Versions of this Item
-
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. (deposited 11 May 2016 09:19)
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. (deposited 25 Jan 2019 11:31) [Currently Displayed]
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)